Enhanced Neuroprotective Effects of Coadministration of Tetrandrine with Glutathione in Preclinical Model of Parkinson’s Disease
Aim. In this study we examined the influence of tetrandrine (Tet) on the neuroprotective effects of glutathione (GSH) in the 6-hydroxydopamine- (6-OHDA-) lesioned rat model of Parkinson’s disease (PD). Methods. Levels in the redox system, dopamine (DA) metabolism, dopaminergic neuronal survival, and...
Saved in:
Main Authors: | Xiang-Yun Li, Guang-Hai Mei, Qiang Dong, Yu Zhang, Zhuang-Li Guo, Jing-Jing Su, Yu-Ping Tang, Xue-Hong Jin, Hou-Guang Zhou, Yan-Yan Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2015/931058 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tetrandrine Inhibits Titanium Particle-Induced Inflammatory Osteolysis through the Nuclear Factor-κB Pathway
by: Zige Liu, et al.
Published: (2020-01-01) -
Teratogenic Effects of Coadministration of Fluoxetine and Olanzapine on Rat Fetuses
by: Azam Bakhtiarian, et al.
Published: (2014-01-01) -
Severe Rhabdomyolysis Associated with Simvastatin and Role of
Ciprofloxacin and Amlodipine Coadministration
by: Nicolas De Schryver, et al.
Published: (2015-01-01) -
Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson’s Disease
by: María Fernanda Urmeneta-Ortíz, et al.
Published: (2024-01-01) -
The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
by: Edward C. Lauterbach, et al.
Published: (2012-01-01)